UnitedHealth Group (UNH) director Flynn reports 65-share dividend equivalent grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
UnitedHealth Group Inc. director Timothy P. Flynn reported a small increase in his holdings of the company’s common stock through an insider transaction dated 12/16/2025. The filing shows an acquisition of 65 shares of common stock at a stated price of $0, described as dividend equivalents paid on vested deferred stock units that are immediately vested and follow the same terms as the underlying units.
After this transaction, Flynn beneficially owned 9,875 shares of UnitedHealth Group common stock directly and 6,033 shares indirectly through a trust. The form is filed for one reporting person and is signed by an attorney-in-fact on Flynn’s behalf.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
FLYNN TIMOTHY PATRICK
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 65 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 9,875 shares (Direct);
Common Stock — 6,033 shares (Indirect, By Trust)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did UNH director Timothy P. Flynn report?
Timothy P. Flynn reported acquiring 65 shares of UnitedHealth Group common stock on 12/16/2025, recorded as dividend equivalents on vested deferred stock units.
What is Timothy P. Flynn’s relationship to UnitedHealth Group Inc.?
Timothy P. Flynn is listed as a Director of UnitedHealth Group Inc. in the insider ownership report.
Who signed the UNH insider report for Timothy P. Flynn?
The report was signed by Faraz A. Choudhry as Attorney-in-Fact for Timothy P. Flynn on 12/18/2025.